3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is ever more attracting clinical scrutiny due to initial evidence suggesting different physiological actions. Current research indicate that 3-HPC may possess independent impacts on the nervous system, arguably playing a role to some of the unanticipated symptoms linked with PCP u